Official FDA signals
Uses openFDA animal adverse-event reports as supporting signals. Reports alone do not establish causation or incidence.
Select medicines and an animal species to review interaction risks, sources and evidence limits. Supports clinical review and does not replace licensed veterinary judgment.
Every result states whether it is a direct rule, controlled extrapolation, FDA signal or an evidence gap.
Every visible conclusion starts with a public source, an explicit license, and an auditable validation workflow.
Uses openFDA animal adverse-event reports as supporting signals. Reports alone do not establish causation or incidence.
References PubMed and PMC literature with source-specific evidence and licensing. Summaries, citations and downloadable originals are distinct.
Publication review and verified-veterinarian feedback are shown separately. Administrator approval is not independent clinical validation.
ZooDDI™ follows CC license terms; extracted data is used to build an original factual database.
Search avian species, reptiles, small mammals, amphibians and ornamental fish. Coverage depends on published rules; a missing match does not establish safety.
The same risk results and evidence. Choose by how often you check.
US$0 / month
50checks / month
US$9 / month
或 US$79 / 年,按年一次支付
1,000checks / month
Sign in to subscribe
Sign in to confirm checkout and manage your subscription.One completed prescription check counts once, including no-match results; failed checks do not count. Paid Pro resets each subscription month from activation; annual Pro still includes 1,000 checks per month. Free resets on the first at 00:00 UTC. Unused checks do not roll over.
Payment does not change evidence grades. Veterinary certification and rule-rating eligibility are verified separately.
Launch allowances shown. Sign in to confirm your current allowance.
Every rule carries an evidence grade and traceable citations, with uncertainty stated explicitly.
Read our public sources, methodology and service limitations before use. Clinical conclusions require the specific source and patient context.
Understanding cross-species extrapolation · Understanding FDA animal safety signals
Read our public methodology and coverage limitations.Put prescriptions, species and risk into one direct clinical HUD. High risks appear first; numbered evidence supports drill-down without presenting inference as certainty.
0.2 mg/kg · POMetronidazole20 mg/kg · POChelonians clear ivermectin slowly and evidence indicates neurotoxicity risk; immediately verify the species and dose.
You do not need to remember terminology first. Describe symptoms, species and timing to get structured direction, then return to page-linked evidence.
Choose or type avian, reptile, small mammal, amphibian and ornamental fish species. More specificity makes review more targeted.
When a result comes from a homologous species or pharmacokinetic mechanism, ZooDDI shows the source species, confidence and cautions instead of calling it a verified rule.
Only a direct rule's review state can be shown as verified. FDA adverse events are supporting signals and cannot alone establish causality.
From prescription input to consensus review, ZooDDI keeps the context of species, citations, source status and uncertainty.
Start with Phase 1 exotic groups or enter the exact species.
Select medicines and the patient species to check every added combination.
Confirm direct evidence, extrapolation, FDA signal or evidence gap before making a clinical decision.
From direct species evidence to source species, inference confidence, FDA supporting signals, source status and review state, every layer keeps an auditable boundary.
Only sources explicitly marked “Original file archived” provide a downloadable original for review.
No. It provides evidence and risk signals; the prescribing decision remains with a licensed veterinarian.
No. Extrapolation shows source species, confidence and cautions. It is a review prompt, not a substitute for species-specific evidence.
No. FDA adverse-event reports are supporting signals and cannot alone establish causality, incidence or comparative product risk.